Ftse Mib
34.444,66
-1,09%
DAX
18.681,34
-0,46%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
71.091,45
-0,50%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ X4 Pharmaceuticals Inc (XFOR) X4 Pharmaceuticals Inc (XFOR) Notizie

XFOR

X4 Pharmaceuticals (XFOR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XFOR
DataOraFonteTitoloSimboloCompagnia
09/05/202412:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XFORX4 Pharmaceuticals Inc
11/03/202422:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
11/03/202421:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
28/02/202423:52Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202422:44Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202422:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XFORX4 Pharmaceuticals Inc
25/01/202422:23Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XFORX4 Pharmaceuticals Inc
09/11/202323:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XFORX4 Pharmaceuticals Inc
18/10/202322:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XFORX4 Pharmaceuticals Inc
25/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XFORX4 Pharmaceuticals Inc
26/06/202322:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XFORX4 Pharmaceuticals Inc
23/06/202321:27Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:XFORX4 Pharmaceuticals Inc
21/06/202312:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XFORX4 Pharmaceuticals Inc
21/06/202312:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:XFORX4 Pharmaceuticals Inc
16/06/202322:05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XFORX4 Pharmaceuticals Inc
09/06/202322:13Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:XFORX4 Pharmaceuticals Inc
01/06/202322:40Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:XFORX4 Pharmaceuticals Inc
01/06/202322:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XFORX4 Pharmaceuticals Inc
26/05/202321:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XFORX4 Pharmaceuticals Inc
04/05/202322:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XFORX4 Pharmaceuticals Inc
27/04/202322:27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XFORX4 Pharmaceuticals Inc
25/04/202322:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XFORX4 Pharmaceuticals Inc
21/03/202321:25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XFORX4 Pharmaceuticals Inc
14/02/202323:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XFORX4 Pharmaceuticals Inc
12/12/202220:35TipRanksX4 Pharmaceuticals (XFOR) Receives a New Rating from Brookline Capital MarketsNASDAQ:XFORX4 Pharmaceuticals Inc
09/12/202212:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:XFORX4 Pharmaceuticals Inc
07/12/202213:12TipRanksX4 Pharma Tanks on Public OfferingNASDAQ:XFORX4 Pharmaceuticals Inc
30/11/202213:35TipRanksB.Riley Financial Keeps Their Buy Rating on X4 Pharmaceuticals (XFOR)NASDAQ:XFORX4 Pharmaceuticals Inc
30/11/202201:05TipRanksBrookline Capital Markets Sticks to Its Buy Rating for X4 Pharmaceuticals (XFOR)NASDAQ:XFORX4 Pharmaceuticals Inc
08/11/202203:07TipRanksX4 Pharmaceuticals (XFOR) Receives a Buy from Stifel NicolausNASDAQ:XFORX4 Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XFOR

La tua Cronologia

NYSE
SCE.PRH
SCE Trust III
LSE
GCG
Golden Rock Global
XE
IPOK
Heidelberger Beteiligung...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network